Mancare Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Mancare Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 4 Products, $2.4M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Mancare Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 4 Products, $2.4M Trade | TransData Nexus

Mancare Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $2.4M Total Trade · DGFT Verified

Mancare Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $2.4M across 4 products in 3 therapeutic categories. Based on 67 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Salbutamol ($989.0K), Theophylline ($928.2K), Proguanil ($354.1K).

Mancare Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Mancare Pharmaceuticals Private Limited pharmaceutical export portfolio — 4 products across 3 therapeutic categories. Source: Indian Customs (DGFT).

Who is Mancare Pharmaceuticals Private Limited? — Company Overview & Market Position

Mancare Pharmaceuticals Private Limited, established on August 9, 1996, is a privately held pharmaceutical company headquartered in Vasai, Maharashtra, India. The company is registered under the Corporate Identification Number (CIN) U24239MH1996PTC101774. It operates as a non-government entity, classified as a private company limited by shares. The authorized capital stands at ₹1.5 million, with a paid-up capital of ₹0.9 million.

Mancare Pharmaceuticals specializes in the manufacturing of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company's product portfolio is concentrated, with its top five products accounting for 100% of its export value. In the fiscal year 2023, the company reported a modest revenue growth of 0.53%, though profitability declined by 20.21%.

What Does Mancare Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Salbutamol$989.0K 2Theophylline

Product Portfolio — Top 4 by Export Value

Mancare Pharmaceuticals Private Limited exports 4 pharmaceutical products across 3 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Salbutamol	Respiratory	$989.0K	28	0.7%	13
2	Theophylline	Respiratory	$928.2K	22	5.9%	5
3	Proguanil	Antimalarial & Antiparasitic	$354.1K	11	0.0%	4
4	Aminophylline	Respiratory & OTC	$175.7K	6	3.0%	4

Mancare Pharmaceuticals Private Limited exports 4 pharmaceutical products across 3 therapeutic categories with a total export value of $2.4M. The top category is Respiratory (78.3% of portfolio), followed by Antimalarial & Antiparasitic (14.5%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Mancare Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

The company's manufacturing facility is located at Plot No. 59, 60, 85, 86, Vasai Municipal Industrial Estate, Dhowali Village, Papdy, Vasai, Maharashtra, 401207. This plant specializes in the production of various pharmaceutical formulations, including tablets, capsules, syrups, and injections. Specific details regarding production capacities and certifications are not publicly disclosed.

3Key Leadership

The leadership team of Mancare Pharmaceuticals Private Limited comprises:

Sagar Hasmukh Shah: Additional Director, appointed on May 9, 2025.

Kalpesh Popatlal Shah: Director, serving since December 5, 1996.

Hasmukh Popatlal Shah: Director, serving since August 9, 1996.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Mancare Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Mancare Pharmaceuticals Private Limited's export activities are primarily focused on Nigeria, where it supplies generic pharmaceutical formulations such as capsules and tablets. The company sells its products to traders in this market. Specific details regarding regulatory approvals or market access in other regions, including the US, EU, UK, Australia, and Japan, are not publicly available.

2Emerging Markets

The company's export activities are primarily focused on Nigeria, where it supplies generic pharmaceutical formulations such as capsules and tablets. Specific details regarding market penetration in Africa, Latin America, and Southeast Asia, as well as WHO prequalification status, are not publicly available.

3Geographic Strategy

Mancare Pharmaceuticals Private Limited's export strategy appears to be concentrated in the Nigerian market, with no publicly available information indicating diversification into other regions. This focus suggests a potential concentration risk, as reliance on a single market can expose the company to geopolitical and economic fluctuations within that region. The company's strategic direction regarding geographic diversification is not publicly disclosed.

Mancare Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Mancare Pharmaceuticals Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history is not publicly available. The company's export activities are primarily focused on Nigeria, and there is no publicly available information indicating FDA approvals or market access in the United States.

2WHO & EU GMP

There is no publicly available information regarding Mancare Pharmaceuticals Private Limited's WHO prequalification status, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. The company's export activities are primarily focused on Nigeria, and specific details about its compliance with international quality standards are not disclosed.

3CDSCO & Indian Regulatory

Specific details regarding Mancare Pharmaceuticals Private Limited's manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), approvals from state drug controllers, or export No Objection Certificates (NOCs) are not publicly available. The company's registered office is located in Thane, Maharashtra, India, and its manufacturing facility is situated in Vasai, Maharashtra.

Mancare Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Mancare Pharmaceuticals Private Limited operates in the generic pharmaceutical formulations sector, exporting products such as capsules and tablets. While specific competitors in the Nigerian market are not publicly disclosed, the company faces competition from other pharmaceutical manufacturers supplying similar products to the region. Market share comparisons and head-to-head analyses are not available due to limited public information.

2Key Differentiators

Mancare Pharmaceuticals Private Limited's key differentiators include its focus on generic pharmaceutical formulations and its established presence in the Nigerian market. The company's product portfolio is concentrated, with its top five products accounting for 100% of its export value. Specific details regarding unique strengths, competitive advantages, or product portfolio distinctions are not publicly disclosed.

3Strategic Position

Mancare Pharmaceuticals Private Limited's current strategic direction appears to be focused on the manufacturing and export of generic pharmaceutical formulations, primarily to the Nigerian market. Specific information regarding the company's future outlook, including plans for diversification into generics, specialty drugs, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services, is not publicly available.

Buyer Due Diligence Brief — Evaluating Mancare Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Mancare Pharmaceuticals Private Limited's export volume and consistency are primarily focused on the Nigerian market, with a total export value of $2.4 million USD across 67 shipments. The company's product portfolio is concentrated, with its top five products accounting for 100% of its export value. Specific reliability indicators, such as on-time delivery rates or customer satisfaction metrics, are not publicly disclosed.

2Certifications to Verify

Importers should verify the following certifications when considering products from Mancare Pharmaceuticals Private Limited:

FDA Approval: To confirm that the products are authorized for sale in the United States, importers should request copies of the FDA approval letters or certificates of compliance.

WHO-GMP Certification: To ensure adherence to international manufacturing standards, importers should obtain a copy of the World Health Organization's Good Manufacturing Practice certificate.

Frequently Asked Questions — Mancare Pharmaceuticals Private Limited

How many pharmaceutical products does Mancare Pharmaceuticals Private Limited export from India?

Mancare Pharmaceuticals Private Limited exports 4 pharmaceutical products across 3 therapeutic categories. The top exports are Salbutamol ($989.0K), Theophylline ($928.2K), Proguanil ($354.1K), Aminophylline ($175.7K). Total export value is $2.4M.

What is Mancare Pharmaceuticals Private Limited's total pharmaceutical export value?

Mancare Pharmaceuticals Private Limited's total pharmaceutical export value is $2.4M, based on 67 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Mancare Pharmaceuticals Private Limited cover?

Mancare Pharmaceuticals Private Limited exports across 3 therapeutic categories. The largest are Respiratory (78.3%, 2 products), Antimalarial & Antiparasitic (14.5%, 1 products), Respiratory & OTC (7.2%, 1 products).

Get Full Mancare Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.